Pharmacokinetics of lornoxicam in three formulations of healthy male Chinese volunteers

LEI Min,HANG Tai-jun,SONG Min,GE Ping,Qu Lan-jin,WEN Ai-dong,YANG Lin
DOI: https://doi.org/10.3969/j.issn.1007-7669.2008.01.005
2008-01-01
Abstract:AIM To establish a selective and sensitive LC-MS/MS for the concentration determination of plasma lornoxieam and study the pharmacokinetics of lornoxieam in three formulations of healthy volunteers. METHODS 24 healthy male Chinese volunteers with 3-way crossover design of a 7-day washout period were randomized to receive a single 8 mg dose of lornoxicam rapid release tablets or conventional regular release tablets orally,or 8 mg lornoxieam injection with intramuscular injection at the buttock.The plasma concentrations of lornoxicam were determined through validated LC-MS/MS method.DAS 2.0 program was carried out for the pharmacokinetic analysis.RESULTS The main pharmacokinetics parameters of lornoxicam in human plasma after 8 mg oral rapid release,regular release tablets,and injection were as follow:c_(max)(1 174±s 246)、(596±158)and(950±230)mg·L~(-1);AUC_(0-24)(4 052±706)、(3 450±966)and(3 838±822)μg·h·L~(-1); AUC_(0-∝)(4 101±715)、(3 543±1 062)and(3 903±854)μg·h·L~(-1);t_(max)(0.5±0.3)、(1.9±1.0)and (0.5±0.3)h;t_(1/2)(3.8±0.7)、(4.1±1.0)and(4.0±0.8)h;MRT(4.6±0.6)、(6.1±1.5)and(5.1±0.8)h;CL(F)(2.0±0.4)、(2.5+0.7)and(2.2±0.5)L·h~(-1);V(F)(11±3)、(14±5)and(11.3±2.1) L,respectively.No significant difference was found between the pharmacokinetics of the rapid release tablets and the injection with the absorption rates and bioavailabilities of the both much better than the conventional regular release tablets.CONCLUSION The established LC-MS/MS test method for lornoxicam sample of human plasma is specific,sensitive,and accurate and the lornoxicam rapid release tablets is bioequivalent with the lornoxicam injection with further improvement of patient compliance.
What problem does this paper attempt to address?